Category Archives: Patients

Perrigo Acetaminophen Infant Suspension Liquid Recall

Share

Perrigo Acetaminophen Infant Suspension Liquid: Recall – Potential Defect with Co-packaged Oral Syringe   [Posted 11/02/2013] AUDIENCE: Consumer, Patient, Pediatrics, Pharmacy, Health Professional ISSUE: The Perrigo Company announced that it has initiated a voluntary, nationwide product recall to the retail … Continue reading

Share
Posted in Consumer Products, FDA 2013, FDA Recall, Healthcare Professionals, Patients, Pediatrics, Pharmacy | Tagged , , , , , , , , , , , , , , | Comments Off on Perrigo Acetaminophen Infant Suspension Liquid Recall

Specialty Medicine Compounding Pharmacy Recall

Share

Specialty Medicine Compounding Pharmacy Certain Unexpired Compounded Sterile Products: Recall – Particulate Matter Found in Vials   AUDIENCE: Pharmacy, Patient, Health Professional   ISSUE:  Specialty Medicine Compounding Pharmacy is voluntarily recalling all lots of certain unexpired human and veterinary sterile … Continue reading

Share
Posted in FDA 2013, FDA Recall, Healthcare Professionals, Patients, Pharmacy | Tagged , , , , , , , , , , , , | Comments Off on Specialty Medicine Compounding Pharmacy Recall

St Jude Amplatzer Atrial Septal Occluder ASO Safety Communication

Share

St. Jude Amplatzer Atrial Septal Occluder (ASO): Safety Communication – Reports of Tissue Erosion AUDIENCE: Cardiology, Risk Manager, Patient ISSUE: FDA is alerting health care providers and patients that in very rare instances, tissue surrounding the Amplatzer ASO can break … Continue reading

Share
Posted in Cardiology, FDA 2013, FDA Notice, FDA Safety Communication, Patients, Risk Manager | Tagged , , , , , , , , , , , | Comments Off on St Jude Amplatzer Atrial Septal Occluder ASO Safety Communication

Cefepime For Injection USP And Dextrose Injection USP Recall

Share

 Cefepime For Injection, USP And Dextrose Injection, USP By B. Braun Medical Inc.: Recall – Visible Particulate Matter AUDIENCE: Pharmacy, Health Professional, Patient ISSUE: B. Braun Medical Inc. is voluntarily recalling one lot of 1g Cefepime for Injection USP and … Continue reading

Share
Posted in FDA 2013, FDA Recall, Healthcare Professionals, Patients, Pharmacy | Tagged , , , , , , , , , , | Comments Off on Cefepime For Injection USP And Dextrose Injection USP Recall

Metoclopramide Injection Ondansetron Injection by Hospira Recall

Share

Metoclopramide Injection And Ondansetron Injection by Hospira: Recall – Glass Strand Particulates Caused By Glass Supplier AUDIENCE: Pharmacy, Patient, Health Professional ISSUE: Hospira, Inc. announced it initiated a voluntary nationwide recall of one lot of Metoclopramide Injection, USP, 10 mg/2 mL … Continue reading

Share
Posted in FDA 2013, FDA Recall, Healthcare Professionals, Patients, Pharmacy | Tagged , , , , , , , , | Comments Off on Metoclopramide Injection Ondansetron Injection by Hospira Recall

Arzerra ofatumumab and Rituxan rituximab Drug Safety Communication

Share

Arzerra (ofatumumab) and Rituxan (rituximab): Drug Safety Communication – New Boxed Warning, Recommendations to Decrease Risk of Hepatitis B Reactivation AUDIENCE: Oncology, Pharmacy, Rheumatology, Patient ISSUE: FDA approved changes to the prescribing information of the immune-suppressing and anti-cancer drugs Arzerra … Continue reading

Share
Posted in FDA 2013, FDA Safety Communication, Oncology, Patients, Pharmacy, Rheumatology | Tagged , , , , , , , , , , , , , , | Comments Off on Arzerra ofatumumab and Rituxan rituximab Drug Safety Communication

Duragesic fentanyl Patches Drug Safety Communication

Share

Duragesic (fentanyl) Patches: Drug Safety Communication – Packaging Changes to Minimize Risk of Accidental Exposure AUDIENCE: Pharmacy, Patient ISSUE: FDA is requiring color changes to the writing on Duragesic (fentanyl) pain patches so they can be seen more easily. FDA … Continue reading

Share
Posted in FDA 2013, FDA Safety Communication, Patients, Pharmacy | Tagged , , , , , , , , , | Comments Off on Duragesic fentanyl Patches Drug Safety Communication

Leiters Compounding Pharmacy Recall

Share

Leiter’s Compounding Pharmacy: Recall – Concerns of Sterility Assurance Bevacizumab Lot No. 08052013@1, expiry 11/03/13 Bevacizumab Lot No. 08052013@4, expiry 11/03/13 Lidocaine/phenylephrine Lot No. 07302013@6, expiry 10/28/13 AUDIENCE: Consumer, Pharmacy, Patient, Health Professional ISSUE: Leiter’s Compounding Pharmacy is voluntarily recalling … Continue reading

Share
Posted in Consumer Products, FDA 2013, FDA Recall, Healthcare Professionals, Patients, Pharmacy | Tagged , , , , , , , , , , , , | Comments Off on Leiters Compounding Pharmacy Recall

Park Compounding Testoserone Cypionate Recall

Share

Park Compounding Sterile Medication: Recall – Concerns of Sterility Assurance AUDIENCE: Consumer, Pharmacy, Patient, Health Professional ISSUE:  Park Compounding is voluntarily recalling one lot of sterile medication Testoserone Cypionate (Sesame Oil) 200mg/ml Lot #05072013@1 Exp: 11/3/2013 for injection in 10ml … Continue reading

Share
Posted in Consumer Products, FDA 2013, FDA Recall, Healthcare Professionals, Patients, Pharmacy | Tagged , , , , , , , , , , | Comments Off on Park Compounding Testoserone Cypionate Recall

Avella Specialty Pharmacy Sterile Medications Recall

Share

Avella Specialty Pharmacy Sterile Medications: Recall – Concerns Of Sterility Assurance At Testing Vendor AUDIENCE: Consumer, Pharmacy, Patient, Health Professional ISSUE: Avella Specialty Pharmacy is voluntarily recalling two compounded sterile medications, Bevacizumab 1.25 mg/0.05 mL PF and Vancomycin PF (BSS) … Continue reading

Share
Posted in Consumer Products, FDA 2013, FDA Recall, Healthcare Professionals, Patients, Pharmacy | Tagged , , , , , , , , , | Comments Off on Avella Specialty Pharmacy Sterile Medications Recall